The Hidden Operational Complexities Of Home Infusion

By Chris Van Raam, PharmD, MBA, chief operating officer, ContinuumRx, an Acelpa Health company and Erica Blanchard, PharmD, vice president of pharmacy operations, California Specialty Pharmacy, an Acelpa Health company

As healthcare continues to shift away from fee-for-service and toward value-based and global payment models, hospitals and health systems face growing pressure to improve patient outcomes while reducing costs. One of the most promising and widely discussed strategies is to transition infusion therapy from the hospital to lower-cost settings, such as an infusion suite or center or, when appropriate, the patient’s own home.

For healthcare leaders, the decision may seem straightforward: deliver infusion treatments in patients’ homes, reduce costs, and improve the patient experience. But that thinking oversimplifies a far more complex reality.

Home infusion may at first seem like a simple sequence: receive a referral, schedule a nurse, have the medication delivered, and begin treatment. But in practice, getting a single patient set up with home infusion requires individualized, multidisciplinary care coordination. Each referral brings a unique set of variables, from clinical appropriateness and patient readiness to nursing availability, medication preparation, and delivery logistics.

What many don’t see is that home infusion is not just a change in the care setting; it is an attempt to recreate the clinical rigor of an acute care environment in a decentralized, variable location. In a hospital or infusion center, care delivery is tightly controlled, with staff, medications, monitoring, and escalation pathways aligned. In the home, those same elements must be orchestrated across individual patient environments, each with its own constraints and variability.

Home infusion is not a simplified version of facility-based care. It is a fundamentally different model—one that replaces centralized infrastructure with a highly coordinated, distributed system. When that complexity is underestimated, the consequences are not theoretical; they are operational.

Determining True Patient Readiness

Determining whether home infusion is the right fit for a particular patient is far more nuanced than it appears. Clinical and payor eligibility is only the starting point. Providers must assess not only whether a therapy can be administered outside a controlled setting but also whether it can be done safely, considering the route of administration, the risk of adverse reactions, and the level of monitoring required.

In practice, this evaluation is highly individualized. Each patient requires a tailored care plan based on the therapy’s characteristics, the patient’s clinical profile, the patient’s response to treatment, and the plan for monitoring the therapy over time. There is no one-size-fits-all approach. Every referral introduces a new set of variables that must be carefully assessed.

In fact, the more challenging considerations are often non-clinical:

• Does the patient have a caregiver who can assist if needed?
• Is the home environment suitable for treatment? Is there reliable electricity, refrigeration, and access to emergency care?
• Can the patient adhere to the therapy schedule without direct supervision?
• Is the patient—or their caregiver—a willing and capable participant in the treatment process?
• Does the patient need a nurse who speaks their preferred language?

Unlike in a hospital setting, where clinical support is continuously available, home infusion shifts a meaningful portion of responsibility to the patient and their support system. Patients are often asked to manage aspects of their therapy that would otherwise be handled by clinical staff, from monitoring symptoms to participating in the administration of their therapy. This requires not only willingness but also training and demonstrated competence.

For example, a patient receiving a biologic therapy may be clinically stable, yet still require close observation during the initial dose. Another patient may meet clinical criteria but lack the support system needed to manage treatment safely at home. In both cases, the decision is not simply clinical, it is operational and behavioral.

At its core, home infusion aims to replicate the safety, rigor, and clinical oversight of an acute care setting in the home. Effective patient selection requires a multidimensional assessment that goes beyond diagnosis to include real-world conditions. When these factors are overlooked, patients may be placed in home infusion settings that are not equipped to support them, introducing risk into what is often assumed to be a lower-risk environment. A more comfortable setting does not make care any less complex.

Synchronizing Staffing Needs

Even when a patient is deemed appropriate for home infusion, delivering care at home introduces a new layer of complexity: finding the right staff to provide it.

Unlike facility-based care, where nurses are centralized and readily available, home infusion relies on a geographically dispersed workforce. Nurses must travel to patients’ homes, sometimes over long distances in rural areas, and adapt to varying environments, safety considerations, and levels of patient support. As a result, nursing availability is not simply a matter of staffing levels. It is shaped by geography, timing, and patient-specific needs. In some areas, there may be limited or no nurses or agencies available, while in others, travel distances or safety concerns can make coverage difficult.

Timing adds another critical layer of complexity. Patients are often on strict dosing schedules that require therapy to be delivered at specific times. This requires aligning nurse availability with medication delivery and patient readiness, often within a narrow window.

The nurse, the medication, and the patient must all arrive at the same place, at the same time, under the right conditions. If one element falls out of sync, the entire referral is at risk. When infusion is delivered at home, there is no centralized backup. No extra nurse down the hall. No controlled setting to absorb delays. Every visit must be planned, coordinated, and executed with precision.

Managing Medication Logistics

If workforce coordination is one layer of complexity, medication logistics is another, equally critical layer. From the moment a referral is received, specialty pharmacy teams begin evaluating whether a medication is appropriate for home infusion and how it will be administered. That includes determining the delivery method, ensuring stability over time, and aligning on a plan that works both clinically and operationally. 

Unlike in a hospital, where medications are prepared and administered immediately, home infusion often requires medications to remain stable over extended periods, sometimes days, while being transported and stored in the patient’s home. This introduces a tightly controlled chain of events: compounding, packaging, temperature management, transport, and delivery.

Some patients may be able to store only a limited supply of medication due to space or equipment constraints, potentially requiring multiple deliveries per week. Others may need additional support, such as specialized refrigeration, to make home-based care viable.

Depending on urgency, medications may be hand-delivered the same day, shipped overnight, or coordinated through caregivers. Each scenario requires different packaging, timing, and temperature controls, all of which must be validated to ensure drug integrity.

Specialty infusion and pharmacy teams serve as the central hub, working with payors, coordinating with nurses, aligning with prescribers, and ensuring that every component of the therapy arrives and functions as intended. In many cases, they “quarterback” the entire process from referral through delivery and beyond.

Monitoring Patients Outside The Hospital

Perhaps the most significant shift from infusion in a hospital setting to a home setting is how care is monitored and managed over time.

In a hospital or infusion center, patients receive continuous clinical oversight during their treatment. At home, providers must build systems that extend clinical oversight into a decentralized environment.

Communication is critical. Home infusion providers must maintain consistent contact with patients, caregivers, nurses, and physicians, ensuring that information flows quickly and accurately across all parties.

This begins with regular check-ins to evaluate how patients are responding to therapy, whether they are experiencing side effects, and whether treatment goals are being met. Many therapies require ongoing lab work to assess effectiveness or adjust dosing. Specialty infusion and pharmacy teams often coordinate these labs, review results, communicate with physicians, and make real-time recommendations for therapy adjustments as needed.

Even with strong systems in place, variability remains. Patients’ schedules change, and they may not be available for a scheduled assessment. External factors such as drug shortages or natural disasters can disrupt therapy and require rapid adjustments. The challenge is not just identifying risk; it is responding to it in real time.

Without clear protocols and experienced coordination, small issues can escalate into adverse events, non-adherence, or even rehospitalization. Home infusion does not eliminate clinical complexity; it redistributes it across a system that must be designed to manage uncertainty without the immediacy of a hospital setting. This is where operational expertise in home infusion therapy becomes the differentiator.

Why The Right Partner Makes The Model Work

Home infusion may improve access to care, reduce costs, and enhance the patient experience for some patients, and success depends on healthcare leaders recognizing that home infusion is not merely an extension of facility-based care. It is a highly coordinated clinical and operational system that must function reliably across a decentralized environment.

When this complexity is underestimated, consequences can include delays in therapy initiation, missed doses, communication breakdowns, and other avoidable complications that can quickly erode both clinical outcomes and cost savings.

The difference between success and failure is not the therapy itself – it is the model used to deliver it. This is where experience matters.

Specialty pharmacies that provide home infusion services are uniquely positioned to manage this complexity. They are built to coordinate across clinical, operational, and logistical domains, serving as the central point of integration among prescribers, nurses, patients, payors, and supply chain partners. In this role, specialty pharmacies do far more than simply dispense medications; they manage the full therapy life cycle from referral and reimbursement through delivery, administration, monitoring, and adjustment. This level of integration may help reduce fragmentation, improve visibility, and enable faster, more informed responses to changing conditions.

When executed well, home infusion can be an excellent alternative for patients who want to discharge or avoid hospitalizations or clinic visits.

For healthcare systems, the implication is clear. Successfully expanding home infusion is not simply a matter of shifting the site of care. It requires partnering with organizations that understand the operational realities and have the infrastructure to manage them at scale.

About The Authors:

Chris Van Raam, PharmD, MBA, BCSCP, is a pharmacy executive with more than 15 years of experience in home infusion and pharmacy operations. His expertise includes home infusion operations, sterile compounding, specialty product management, ambulatory infusion services, payer strategy, and multi-site leadership. Van Raam currently serves as chief operating officer for ContinuumRx and Continuum Health, where he oversees complex home infusion and ambulatory infusion operations across multiple sites. He is actively involved in industry advocacy and professional leadership through the National Home Infusion Association (NHIA), including participation on the Sterile Compounding Practice Committee and Government Affairs Committee.

Erica Blanchard, PharmD, MBA, is an operations executive with extensive experience across specialty pharmacy, home infusion, ambulatory infusion, clinical trials, patient safety, and retail and inpatient pharmacy operations. She has led strategic and operational initiatives focused on process optimization, patient access, site-of-care solutions, and scalable growth within complex healthcare organizations. As vice president of pharmacy operations for CSP/HSP, Blanchard oversees pharmacy, nursing, and operational functions across California and Hawaii, with a focus on enhancing patient experience, strengthening clinical operations, and driving sustainable growth and operational efficiency.

Legal Disclaimer:

The content provided in this article is based on industry experience and is for informational purposes only. It is not intended to serve as legal, regulatory, or reimbursement advice. While we make every effort to provide accurate and up-to-date information, the details shared here should not be considered a substitute for professional consultation or advice.

By accessing this content, you agree to hold harmless the author, publisher, and any associated parties from any claims, liabilities, or damages arising from the use or interpretation of this content.

©2026 Acelpa Health, LLC. All rights reserved.